Current and future perspectives in psychiatric drug discovery

Drug News and Perspectives

Volumn 22, Issue 6, 2009, Pages 360-364

  Alderton, Wendy ^a   Karran, Eric ^b   Ward, Simon ^c  

^a SUMMIT PLC   (United Kingdom)

^b JOHNSON AND JOHNSON   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOZAPINE; CYTISINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DULOXETINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; JNJ 37822681; JNJ 473265; METHYLPHENIDATE; MODAFINIL; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PAPAVERINE; PAROXETINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; RISPERIDONE; SERTRALINE; TP 10; UNCLASSIFIED DRUG; VARENICLINE; VENLAFAXINE;

ANHEDONIA; BODY WEIGHT; CATALEPSY; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITION; CONFERENCE PAPER; DEPRESSION; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG STRUCTURE; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUNTINGTON CHOREA; HYPERPROLACTINEMIA; NEUROSCIENCE; NONHUMAN; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SMOKING CESSATION; STRUCTURE ACTIVITY RELATION; TOBACCO DEPENDENCE;

ANIMALS; COGNITION; DEPRESSIVE DISORDER, MAJOR; DRUG DESIGN; DRUG DISCOVERY; HUMANS; SCHIZOPHRENIA; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS;

EID: 70350560256     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2009.22.6.1380328     Document Type: Conference Paper

References (13)

1. Robbins, T.W. Special issue on cognitive enhancers. Psychopharmacology 2009, 202(1-3): 1.
2. Mehta, M.A., Calloway, P. and Sahakian, B.J. Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder. J Psychopharmacol 2000, 14(3): 299-302.
3. Elliott, R., Sahakian, B.J., Matthews, K., Bannerjea, A., Rimmer, J. and Robbins, T.W. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 1997, 131(2): 196-206. (Pubitemid 27261609)
4. Rogers, R.D., Blackshaw, A.J., Middleton, H.C. et al. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology 1999, 146(4): 482-491
5. Goetghebeur, P. and Dias, R. Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat-a back translational study. Psychopharmacology 2009, 202(1-3): 287-93.
6. Dackis, C. and O'Brien, C. Glutamatergic agents for cocaine dependence. Ann NY Acad Sci 2003, 1003: 328-345
7. Porrino, L.J., Daunais, J.B., Rogers, G.A., Hampson, R.E. and Deadwyler, S.A. Facilitation of task performance and removal of the effects of sleep deprivation by an ampokine (CX717) in nonhuman primates. PLoS Biol 2005, 3(9): 1639-1652
8. Le Pen, G., Gourevitch, R., Hazane, F., Hoareau, C., Jay, T.M. and Krebs, M.O. Peripubertal maturation after developmental disturbance: a model for psychosis onset in the rat. Neuroscience 2006, 143(2): 395-405. (Pubitemid 44781063)
9. Rush, A.J., Trivedi, M.H., Wisniewski, S.R. et al. Acute and longer-term outcomes in depressed outpatients requiring one of several treatment steps; A STAR*D Report. Am J Psychiatry 2006, 163: 1905-1917
10. Krishnan, V. and Nestler, E.J. The molecular biology of depression. Nature 2008, 455(7215): 894-902.
11. Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S. and Krystal, J.H. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47(4): 351-354 (Pubitemid 30109248)
12. Lieberman, J.A., Stroup, T.S., McEvoy, J.P. et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. N Engl J Med 2005, 353(12): 1209-1223
13. Kapur, S. and Seeman, P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry 2001, 158(3): 360-369 (Pubitemid 32205190)